Healthcare Industry Insights: September 2019

Monday 30 September 2019

Electronic Lab Notebook Market - Growth Opportunities and Top Companies Analysis

The global Electronic Lab Notebook Market size is expected to reach USD 768.2 million by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 4.8% during the forecast period. Increasing requirement for life science and pharma industries to comply with regulatory requirements has promoted the incorporation of Electronic Lab Notebook (ELN) as it helps simplify the lab process and reduce time.

Rising demand for automated laboratory process such as cloud based electronic lab notebook, ELN embedded with SDMS solutions and supportive government initiatives, are expected to propel the market over the forecast period. Asia Pacific is expected to exhibit lucrative growth over the forecast period owing to increasing demand of Contact Research Organizations (CROs). Moreover, reduced operational cost, remote access, real time data tracking are contributing to the rising demand.

U.S. electronic lab notebook Market

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/electronic-lab-notebook-eln-market

Further key findings from the report suggest:

Increasing demand for automation in lab activities are anticipated to create growth opportunities in near future
Cross disciplinary accounted for the largest revenue share of the product segment in 2018, owing to its usage in multiple disciplines and other added advantages such as customized features and coordination across the domain
Web hosted/cloud based delivery mode held the largest share of electronic lab notebook market in 2018 owing to its real time data analysis, remote access, and reduced IT manpower
Proprietary held the largest revenue share of the license segment due to the increasing adoption in life science and pharmaceutical industries as compared to open source ELN
North America held the dominant market share in 2018, due to supportive government initiatives and presence of large number of industry players
Asia Pacific is anticipated to witness lucrative growth due to increase in number of CROs and untapped opportunities
Some of the key companies are Thermo Fisher Scientific, Inc.; Core Informatics;Arxspan, LLC; LabVantage Solutions, Inc.; Benchling, Inc.; LabLynx, Inc.; Agilent Technologies; Dassault Systemes SE; KineMatik Inc.; and Abbott Informatics

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/

Contract Manufacturing Market Demand, Share, Size & Future Growth Trends

The global Contract Manufacturing Market size is expected to reach USD 281.6 billion by 2026 registering a CAGR of 7.0%, according to a new report by Grand View Research, Inc. Increasing demand for advanced products is major factor driving the market. Equipment manufacturers are outsourcing the manufacturing services of medical devices to third parties, mainly in emerging nations. Further, rising cases of heart disorders are boosting the demand for cardiac devices, thereby positively affecting the market growth. Budget scrutiny in developed countries, pricing pressure, and changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by OEMs.

This trend is expected to boost the medical device manufacturing outsourcing to emerging countries like India and China. This paradigm shift from in-house manufacturing to contract manufacturing in the pharmaceutical industry has resulted in increased focus of the companies on Contract Development & Manufacturing Services (CDMOs). These services have effectively addressed the concerns regarding pharmaceutical manufacturing as well as significantly accelerated the commercialization of products.

Moreover, growing geriatric population across the globe and consequent rise in age-related diseases have stimulated the progress of pharmaceutical clinical research outsourcing, thus leading to contract manufacturing industry growth. Asia Pacific was the dominant market for medical device outsourcing in 2018, owing to lower cost and easy availability of skilled human resources. Rise in the number of medical device manufacturing companies and such companies vying to enter regional markets, such as India and China, is further expected to contribute toward the growth of this market.

Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/contract-manufacturing-market

Further key findings from the study suggest:

Increasing use of medical devices due to rising prevalence of various diseases, complexity in manufacturing the devices, and growing trend of outsourcing are expected to drive the market
Finished dose formulations segment is anticipated to expand at the fastest CAGR from 2019 to 2026 due to high demand from CROs
Low cost of conducting clinical trials in Asia Pacific is encouraging the industry participants to shift their manufacturing units to the region, which further boosts the market growth
The major companies in the contract manufacturing market focus on outsourcing production capabilities to strengthen their presence in the market and expand their product portfolio
Some of the key companies in the market are Tecomet INC; Jabil, Inc.; Celestica, Inc.; Integer Holdings Corp.; Plexus Corp.; Sanmina Corp.; West Pharmaceutical Services, Inc.; Flex Ltd.; Cantel Medical Corp.; Viant, Inc.; Synecco Ltd.; and Angiplast Pvt. Ltd.

Tourniquet Systems Market - Key Drivers, Major Manufactures, Trends and Forecast

The global Tourniquet Systems Market is expected to reach USD 594.8 million by 2025, according to a new report by Grand View Research, Inc. Growing incidence of industrial & road accidents and major falls has been a major factor driving market growth. In addition, rapid increase in the number of hospitals and surgical care centers has led to increased application of tourniquets.

Tourniquets are majorly used when hemorrhages cannot be controlled with direct pressure or selective clamping of bleeding vessels. Certain advantages in modern surgical tourniquet systems such as safety, accuracy, and reliability have resulted in widespread adoption of these devices in orthopedic surgeries. Furthermore, technologically advanced tourniquet systems are now integrated with a wide range of pneumatic cuffs that help optimize the performance of the overall system. However, reusable cuffs might result in transmission of infection, which would consequently raise hospital costs and may hinder the growth of market during the forecast period.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/tourniquet-systems-market

Further key findings from the report suggest:

The market study suggests that tourniquet cuffs dominated the overall market in 2016 owing to their increasing applications in orthopedics, trauma, and emergency settings.
Amongst the application segments, hospitals occupied the largest share as they are effective in arresting life‐threatening external hemorrhage caused due to limb injury
In addition, the non-institutional application segment is expected to grow rapidly due to the potential application of tourniquets in military war settings.
The Advanced Trauma Life Support (ATLS) recommends that “the judicious use of a pneumatic tourniquet may be helpful and lifesaving” in cases of major arterial hemorrhage caused by military wars
North America dominated in 2016 owing to presence of an excellent healthcare infrastructure, rise in the number of road accidents, and increasing adoption of advanced tourniquet devices
The Asia Pacific region is anticipated to witness significant growth during the forecast period. It will have one of the widest consumer base of tourniquets owing to huge population, increasing industrial & road accidents, and commendable financial support from various governments.
Some of the major companies operating in this market are Delfi Medical, Zimmer Biomet, Hammarplast Medical AB, VBM Medizintechnik GmbH, Stryker, ulrich medical, and Rudolf Riester GmbH

Healthcare Mobility Solutions Market Size Worth $227.1 Billion By 2025

The global Healthcare Mobility Solutions Market is expected to reach USD 227.1 billion by 2025, according to a new study by Grand View Research, Inc. The market is driven by increasing demand for digitalization of healthcare. Rising health-related expenditure is the biggest issue many countries are facing nowadays. Hospitals are struggling to provide quality care and cost-effective services to patients. Moreover, political instability, lack of proactive initiatives, and economic stress are the factors questioning the R&D funding in developing nations.

Despite sufficient funding and insurance programs, there has been a constant increase in health expenditure in the U.S., affecting services offered by providers. To overcome this, healthcare mobility services are the best solutions, which is anticipated to propel the demand for these devices.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/healthcare-mobility-solutions-market

Further Key Findings From the Study Suggest:

Enterprise mobility platforms are anticipated to show upward shift in the forecast period owing to the growing demand from hospitals and other caregivers, to manage and optimize operational efficiency
mHealth application segment is expected to exhibit fastest growth rate over the forecast period. This can be attributed toward the growing adoption of mHealth apps by patients and care providers for remotely accessing patient health information
Healthcare mobility solutions found wide applications in workforce management, to improve the operational capabilities of the employees and increase productivity
Patient care management practices are anticipated to show lucrative CAGR over the forecast period due to rising patient concerns and demand for continuous monitoring
Patients are anticipated to use the healthcare mobility solutions on a large scale in coming years, owing to rising awareness levels and penetration of mHealth apps
Asia Pacific is expected to grow at an exponential CAGR as a consequence of high unmet needs and rapidly evolving pharma industry along with the growing awareness levels
The key participants are involved in rigorous strategic activities, such as collaborative agreements & acquisitions, to gain competitive advantage in the market
For instance, In April 2016, McKesson Acquired Biologics, Inc.a North Carolina-based biologics company that offers oncology pharmacy services to patients & providers and solutions to manufacturers & payers

Narcolepsy Therapeutics Market - Growth Opportunities and Top Companies Analysis

The global Narcolepsy Therapeutics Market is expected to reach USD 3.85 billion by 2025, according to a new report by Grand View Research, Inc. The increasing awareness about this sleep disorder among public and healthcare providers is a key factor contributing to the market growth.

The Narcolepsy Network has estimated that out of every 2,000 people 1 is afflicted by this condition. Moreover, Narcolepsy UK states that around 25% patients are identified and remaining 75% are untreated as they remain undiagnosed or are misdiagnosed, which is alarming. Some organizations and networks are constantly working to spread awareness about this condition among the patients and physicians.

U.S. narcolepsy therapeutics market

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/narcolepsy-therapeutics-market

Further key findings from the report suggest:

The narcolepsy therapeutics market is expected to grow substantially owing to the worldwide increasing incidence of this disorder.
Narcolepsy with cataplexy was identified as the largest type segment in 2016. It is expected to retain its position throughout the forecast period owing to the rising cases of cataplexy in patients suffering from narcolepsy.
Narcolepsy without cataplexy is likely to witness the fastest growth over the forecast period due to increasing awareness about Excessive Daytime Sleepiness (EDS) through various mediums, such as awareness campaigns
Sodium oxybate dominated the product segment in terms of revenue share in the year 2016, and it is also expected to be the fastest growing segment over the forecast period. Drugs belonging to this class have higher costs and favorable coverage policies.
Xyrem is the only FDA-approved drug in this category and is extensively prescribed for the treatment of cataplexy and EDS. American Academy of Sleep Medicine (ASSM) recommends it as a standard treatment of this disorder.
Europe dominated the regional market in terms of revenue share in 2016 because of increase in capital investments and existence of established healthcare infrastructure along with a large target population
The H1N1 influenza postvaccination pandemic of the year 2009 has resulted in growth of number of narcolepsy patients
Asia Pacific is likely to exhibit fastest growth during the forecast period due to the rising healthcare expenditure in this region, rising awareness among people, highest prevalence in Japan, and presence of emerging economies such as China & India
Some of the major market players are Jazz Pharmaceuticals PLC;Teva Pharmaceutical Industries Ltd.;Graymark Healthcare, Inc.;Addrenex Pharmaceuticals, Inc.; and BIOPROJET.
Mergers and acquisitions are strategic initiatives undertaken by these market players in an attempt to remain competitive. In addition, companies are expanding their geographical presence to untapped markets.

Cancer Stem Cells Market - Growth Opportunities and Top Companies Analysis

The global Cancer Stem Cells Market size is expected to reach USD 1.6 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.98% during the forecast period. Although stem cell-based cancer treatment is facing regulatory and ethical challenges, the market is growing worldwide. With increasing awareness about these cells, there is steady growth in the R&D for the development of effective and novel treatment methods based on stem cells.

Furthermore, continuous rise has been observed in the number of research studies on cancer stem cells (CSCs) being published. These studies have helped healthcare professionals gain insights into CSCs biology and their signaling pathways. This is expected to create tremendous growth prospects for the market.

Furthermore, improvements in experimental approaches, in particular, in vitro assay systems have enabled scientists to establish relationship between different cell types in a tumor and their microenvironment. This has led to development of a broad therapeutic portfolio for CSCs and their associated key pathways for restricting growth of the tumor and providing improved clinical outcome.

North America Anti-Cancer Stem Cell Therapeutics Market

North America Anti-Cancer Stem Cell Therapeutics Market

Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/cancer-stem-cells-market

Further key findings from the report suggest:

The anti-CSC therapeutics segment accounted for a significant share owing to increasing R&D activities for the development of novel therapeutics
Anti-CSCs therapeutics/agents include agents that target key pathways, surface markers, immuno-evasion & tumor microenvironment, along with nanoparticle-based therapies. As key pathways play a major role in tumor regulation, pathway inhibitors captured the largest share owing to the presence of a broad portfolio of products under pipeline
With rising prevalence of bladder cancer, the segment is expected to exhibit the highest CAGR of 10.47% during the forecast period
North America held the largest share in 2016 owing to presence of a large number of facilities in the U.S. that offer stem cell services
Asia Pacific is likely to emerge as the fastest growing regional market owing to increasing investments by various agencies to accelerate research activities in Asian countries
Some of the prominent players in the market are Thermo Fisher Scientific, Inc.; AbbVie, Inc.; Merck KGaA; Bionomics; and Lonza.

Mobile Stroke Unit Market - Growth Opportunities and Top Companies Analysis

Global Mobile Stroke Unit Market is expected to reach USD 9.4million by 2022, according to a new report by Grand View Research Inc.The demand for mobile stroke unit is expected to upsurge owing to increasing demand for specialized emergency rooms on wheel to increase the stroke survival rate.

The incidence rate of stroke is high owing to the lack of awareness amongpeople related to the primary stroke signs and hence the government of developed economies such as the U.S. has established many initiatives at the national level to address this issue. Some of them are Act FAST, Stroke Training and Awareness Resources (STARS), stroke program, and cryogenic stroke awareness.

Growing healthcare cost burden has also increased the percentage of research funding for stroke. In April 2015, the Health Economics Research Centre at Oxford University compared the research spending for stroke from 2008 to 2012. The result established the fact that the percentage of stroke research funding had increased from 1% to 3%. In 2012, the government and charity spending for stroke in the UK was around USD 4.14 billion.

Stroke primarily occurs owing to obesity, high blood pressure, cholesterol, and smoking habits. 87% of the stroke is ischemic in nature due to the artery blockage in high blood pressure patients. Obesity leads to difficulty in blood circulation as the body has high fat.
Global Mobile Stroke Units Market, 2012-2022, (USD Million)

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/mobile-stroke-unit-market

Further key findings from the report suggest:

The U.S. is the most potential market owing to increasedstroke research funding and programs undertaken to increase awareness and high penetration of telemedicine technology. In 2011, the U.S. government spent over USD 302 million for stroke research to prevent the primary signs of stroke such as atrial fibrillation and molecules discovery to treat them. The January 2015 report released by the American Hospital Association, surveyed that in 2013, 52% of hospitals used Telehealth, while 10% implemented it. Consumers are willing to use the Telehealth services (74%) highlighting the fact that telemedicine is highly adopted in the U.S.
Germany is another potential market owing to the various research funds by the European Union to undertake cardiac research in relation to atrial fibrillation. The ‘RETRAINER’ project was supported by nine partners from Germany, Italy, Austria, and Switzerland. In March 2003, German competence Network on Atrial Fibrillation (AFNET) was formed to investigate the reason of arrhythmia and improving patient care. The concept of mobilestroke unit originated from Germany, where the University of Saarland placed a portable CT scanner in ambulance along with a neurophysiologist to analyze the survival rate instroke patients. The concept was then revolutionized and the world’s first MSU named STEMO came in to existence.
The UK experiences around 152,000 stroke cases and an annual healthcare cost of USD 12.73 billion. The increasing concern for the lack of stroke awareness led to the foundation of the Act FAST campaign in February 2009. In February 2015, the NHS Lewisham Clinical Commissioning Group and the Public Health England together supported the Act FAST campaign highlighting the common signs of mini-strokes and strokes. After the inception of this program, 38,600 people have additionally gone to hospitals calling 999, the emergency number.
Manufacturers are also conducting collaborative exercises to study the effect of pre-hospitalization treatment against hospital stroke treatment. In July 2012, Neurologica Corporation and Meytec partnered to develop world’s first comprehensive mobile stroke ambulance. VIMED STEMO combines Meytec’s telemedicine technology with Neurologica’s CT scanner. The state-of-the-art CereTomallows real time imaging, thus reducing the treatment. To address increasing healthcare cost burden, the European nation funded a robotic project to speed up stroke rehabilitation.
Some key players of MSTUs market includeMeytec, Nueurologica Corporation, Excellance, Frazer, and Falck.

Sunday 29 September 2019

Long Term Care Market : Future Demand, Market Analysis & Outlook, 2026

The global Long Term Care Market size is expected to reach USD 1.7 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.5% CAGR during the forecast period. The market is expected to grow primarily owing to rising prevalence of target diseases, especially Alzheimer’s and other dementias, among the aging population. In addition to this, increasing awareness about different long term care (LTC) facilities and the increasing medical coverage for home healthcare are likely to benefit market growth.

According to data published by the United Nations in 2017, it has been estimated that the number of people above 60 of years of age is expected to double between 2017 and 2050. In 2017, the geriatric population was estimated to be 962 million globally. In August 2018, it was estimated that around 52.0% of the people turning 65 years are more likely to take rely on some type of LTC services in the years to come. There has also been a shift toward in-home care from LTC. The number of nursing facilities has reduced over the past several years, while the prevalence of in-home nursing programs have doubled.

Developing economies make for lucrative markers as far as home healthcare is concerned. India, for instance, has many home healthcare startups such as Health Care at Home, Zoctr, Vatsalya, Zozz, Life Circle Health Services, Healers at Home, and the Nightingales, a factor that has worked in its favor. In India, Portea is one of the market leaders in home healthcare. In November 2017, Portea raised USD 26.0 million in the Series C funding for better home healthcare facilities.

Growing medical coverage by government and private insurers has had a positive impact on market growth. According to the Hospice Association of America, Medicare pays USD 173 per day for inpatient respite care, USD 744 per day for general inpatient care, USD 193 per day for routine homecare, and USD 41 per hour for continuous homecare. Moreover, in 2016, Medicare paid a total of USD 16.9 billion to hospice providers, and the average spending per Medicare hospice patient was USD 11,820.0.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/long-term-care-services-market

Further key findings from the study suggest:

In 2018, the home healthcare segment held the largest market share owing to increasing awareness regarding such facilities, cost savings offered by them as compared to hospital stays or nursing homes, and proactive health monitoring
The home healthcare segment is expected to witness rapid growth in developing nations owing to increasing need for geriatric care, presence of double-income households, and ongoing social changes
Hospice is the fastest growing segment owing to increasing incidence rate of Alzheimer’s and dementia and an increase in post-hospital care. Moreover, the coverage offered by both Medicaid and private insurers has relieved residents from out-of-pocket payments that have to be borne by them
North America dominated the long term care market in 2018, majorly driven by advanced medical infrastructure, awareness about the advantages of home health services, rising geriatric population, and government support. Around 13% of the people in U.S. are 65 years or above and it is expected that by 2050, one in five Americans would be at least 65 years of age
Asia Pacific is the fastest growing market owing to increasing rate of chronic diseases, the increasing disposable incomes, and decreasing working population. For instance, in China, the one-child policy has eventually decreased the working population as compared to the older population
Industry players are continuously investing in expanding and revamping existing facilities. For instance, in February 2019, Genesis HealthCare underwent a real estate partnership with Next Healthcare Capital. The deal involved 15 skilled nursing facilities previously leased from Welltower Inc.
Key players operating in the global market include Brookdale Senior Living, Inc.; Sunrise Carlisle, LP; Atria Senior Living Group; Extendicare, Inc.; Senior Care Centers of America; Kindred Healthcare, Inc.; Genesis Healthcare Corp.; Home Instead Senior Care, Inc.; Capital Senior Living Corporation; and Diversicare Healthcare Services, Inc.

Thursday 26 September 2019

Cardiovascular Devices Market - Current Trends and Opportunities

Global Cardiovascular Devices Market is anticipated to reach USD 121 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population, sedentary life style coupled with unhealthy dietary habits is spurring the prevalence of cardiovascular diseases. Constant rise in the patients suffering from cardiovascular diseases and is expected to drive market growth during the forecast period.

Governments are trying to limit hospital readmissions to reduce the prevalence of hospital acquired infections (HAIs) by imposing penalties on hospitals. As a result, adoption of home healthcare, remote patient monitoring, and long term care services is rapidly increasing. Thus, demand for cardiovascular devices is increasing from hospitals, patients based in home settings, and long term care centers.

In addition, favorable government policies such as reimbursement coverage are fueling adoption of these devices. Thus, increasing target patient population, rising acceptance of home healthcare, and favorable government policies are some of the major factors driving the growth of the global cardiovascular devices market.

On the other hand, high device cost and stringent regulatory approval procedure are some of the prime factors challenging the growth of the market. In addition, lack of skilled professionals to perform surgical procedures using advanced devices is impeding the adoption of new devices.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/cardiovascular-devices-market

Further key findings from the study suggest:

Availability of minimally invasive surgical devices coupled with high surgical cost is resulting in higher revenue share of surgical devices. As a result, surgical devices segment dominated the overall market in 2015.
Diagnostics and monitoring device segment is anticipated to grow at the fastest growth rate of 8.4% during the forecast period. Government initiatives to promote early diagnosis of the diseases, increasing adoption of home healthcare services and long term care centers is primarily affecting the growth of diagnostic and monitoring segment positively.
North America dominated with market share of 42.3% of the global market in 2015. Presence of large pool of target population, reimbursement coverage and high adoption rate for advanced treatments are some of the factors driving the growth of the cardiovascular devices market in North America.
Furthermore, favorable government policies and presence of well-defined regulatory framework are some of the factors augmenting the market growth in North America.
Asia Pacific is anticipated to register significant growth during the forecast period. Growth of the region would primarily attribute to anticipated rise in geriatric population prone to cardiac diseases and booming medical tourism in Asia Pacific.
Moreover, presence of rapidly developing countries such as India and China are expected to render positive growth to the Asia Pacific market. Government initiatives to improve healthcare infrastructure, increasing healthcare expenditure and increasing demand for advanced healthcare facilities are some of the factors anticipated to push the market in India and China towards swift growth.
Major players contributing to the global market include, Medtronic plc, Becton Dickinson and Company, Cardinal Health, Inc., Boston Scientific Corporation, B. Braun Melsungen AG and Abbott Laboratories, Inc., Cook Medical, Inc., Terumo Cardiovascular Systems Corporationand St. Jude Medical, Inc.
Competition among the key players would depend upon several factors included but not limited to manufacturing capacity, strong distribution network, pricing strategy and product innovation

Anti-Snoring Devices & Snoring Surgery Market - Industry Analysis and Outlook

Global Anti-Snoring Devices And Snoring Surgery Market is expected to reach USD 1.84 billion by 2024, according to a new report by Grand View Research, Inc. The anti-snoring devices and snoring surgery market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing awareness levels about the ill effects of snoring, rising elderly and obese population, the presence of an unexploited consumer base, and the increasing consumption of alcohol and cigarettes. However, factors such as the cost prohibitive nature of the products, limited efficacy of the presently available treatments, and the presence of an unpropitious reimbursement scenario are likely to hinder the growth of the market.

The market is segmented into anti-snoring devices and snoring surgery segments. The anti-snoring devices segment includes oral appliances, nasal devices, position control devices, chin straps, tongue stabilizing devices, and expiratory positive airway pressure therapy devices. The surgery segment includes uvulopalatopharyngoplasty, laser-assisted uvulopalatoplasty, radiofrequency ablation, sclerotherapy, pillar procedure, and others. North America and Europe are the major shareholders of this industry due mainly to the increasing awareness associated with available treatment options and the eventual rise in popularity and adoption of these products. The Asia Pacific region is expected to witness high growth as a consequence of the untapped population base characterized with a snoring condition, higher levels of awareness regarding the effects of snoring, and the presence of well-established players in the sector.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/anti-snoring-devices-snoring-surgery-market

Further key findings from the study suggest:

North America is estimated to lead the industry with the largest market share in 2015.This growth is attributed to the rapidly increasing popularity and the resultant high market penetration of such treatment devices. Asia Pacific is expected to exhibit the highest growth rate owing to the large untreated population and the rising awareness levels with regard to treatment options and the notorious health consequences associated with this condition.
In surgery, somnoplasty is estimated to be the fastest growing segment due largely to factors, such as low cost, reduced surgical trauma, less invasive, and chances of fewer complications in comparison to the traditional surgery procedures
The anti-snoring devices and snoring surgery market comprises several local as well as global players. Some key market players include Tomed Dr. Toussaint GmbH, Apnea Sciences Corporation, and Meditas Ltd., among others. The companies have adopted several organic and inorganic strategies in order to gain prominence in this sector. A few of these strategies include geographic expansion, new product launches, new product development, partnerships, collaborations, and mergers and acquisitions, among others. For instance, in March 2015, Meditas Ltd. launched nasal dilators for uninterrupted flow of air.